Skip to main content
. 2023 Oct 19;73(6):477–487. doi: 10.1007/s13224-023-01838-9

Table 4.

Socio-demographic and clinical characteristics of women who opted for MTP from all the four centers

Socio-demographic and clinical characteristics First wave (22 March 2020 to 31st December 2020) Second wave (21 March 2021 to 30 June 2021) Third wave (15 December 2021 to 10 February2022) Total cases (%) (all three Covid waves)
Age(years)
 ≤ 18 1 1 2 (0.4%)
18–25 79 34 60 173 (35.9%)
25–30 56 38 50 144 (29.9%)
 ≥ 30 66 40 57 163 (33.8%)
Total 202 113 167 482 (100%)
Obstetric Profile
Unmarried 5 2 1 8 (1.7%)
Primigravida 61 38 46 145 (30.1%)
Gravida-2 66 44 63 173 (35.9%)
Gravida-3 and above 70 29 57 156 (32.3%)
Total 202 113 167 482 (100%)
Gestational age at admission
Up to 7 weeks 108(44.3%) 60 76 244 (50.6%)
7 weeks–12 weeks 46 25 43 114 (23.6%)
12 weeks–20 weeks 48 28 25 101 (20.9%)
 > 20 weeks 23 23 (4.9%)
Total 202 113 167 482 (100%)
Methods of MTP
Medical method of abortion (MMA) 60 65 97 222 (46.1%)
Surgical (MVA/EVA/D&E) * 142(54.6%) 48 70 260 (53.9%)
Total 202 113 167 482 (100%)
Complications during/after MTP
Incomplete abortion 17 12 26 55 (11.4%)
Excessive Bleeding P/V 4 2 7 13 (2.7%)
Uterine perforation 1 1 2 (0.4%)
No complication 180 99 133 412 (85.5%)
Total 202 113 167 482(100%)
Post-abortion contraception
Barrier 74 24 31 129 (26.8%)
IUCD** 31 26 35 92 (19.1%)
Sterilization 2 10 10 22 (4.5%)
Hormonal-oral/injection 62 34 47 143 (29.7%)
No contraception/not willing 33 19 44 96 (19.9%)
Total 202 113 167 482 (100%)

*MVA Manual Vacuum Aspiration

*EVA Electric Vacuum aspiration

*D&E Dilatation and Evacuation

**IUCD Intrauterine contraceptive device